© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
ANI Pharmaceuticals, Inc. (ANIP) stock surged +1.37%, trading at $80.58 on NASDAQ, up from the previous close of $79.49. The stock opened at $79.57, fluctuating between $78.84 and $82.04 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 22, 2026 | 79.57 | 82.15 | 78.83 | 80.58 | 477.42K |
| Jun 18, 2026 | 81.00 | 81.00 | 78.38 | 79.49 | 351.43K |
| Jun 17, 2026 | 83.00 | 83.35 | 79.98 | 80.52 | 301.55K |
| Jun 16, 2026 | 82.69 | 83.25 | 82.17 | 83.00 | 308.4K |
| Jun 15, 2026 | 82.16 | 82.99 | 81.25 | 82.29 | 293.87K |
| Jun 12, 2026 | 82.10 | 83.66 | 80.75 | 81.68 | 179.75K |
| Jun 11, 2026 | 82.07 | 82.28 | 81.04 | 81.65 | 167.45K |
| Jun 10, 2026 | 81.58 | 83.97 | 81.33 | 81.85 | 268.47K |
| Jun 09, 2026 | 81.05 | 82.25 | 80.77 | 81.20 | 271.94K |
| Jun 08, 2026 | 80.88 | 81.50 | 80.12 | 80.13 | 251.83K |
| Jun 05, 2026 | 79.77 | 81.31 | 79.25 | 81.11 | 338.03K |
| Jun 04, 2026 | 76.00 | 80.21 | 76.00 | 79.20 | 548.94K |
| Jun 03, 2026 | 74.24 | 75.85 | 73.54 | 75.23 | 252.93K |
| Jun 01, 2026 | 78.48 | 79.49 | 76.44 | 76.71 | 427.93K |
| May 29, 2026 | 80.73 | 81.30 | 78.13 | 78.51 | 429.87K |
| May 28, 2026 | 81.53 | 82.73 | 80.82 | 81.11 | 174.11K |
| May 27, 2026 | 82.20 | 82.58 | 81.02 | 81.76 | 335.19K |
| May 26, 2026 | 82.93 | 83.75 | 81.07 | 81.41 | 456.07K |
| May 22, 2026 | 82.80 | 83.52 | 81.28 | 82.72 | 562.39K |
| May 21, 2026 | 81.54 | 83.20 | 80.73 | 82.77 | 324.14K |
ANI Pharmaceuticals, Inc. operates as a biopharmaceutical firm, concentrating on the development, production, and commercialization of both proprietary (branded) and unbranded (generic) prescription medications across the United States and Canada. The company's primary focus areas include manufacturing controlled substances, treatments for oncology, hormones and steroids, injectable drugs, and various other pharmaceutical preparations. Its robust manufacturing capabilities encompass a range of dosage forms, such as oral solid products, semi-solids, liquid formulations, and topical agents, as well as highly potent compounds. Furthermore, ANI Pharmaceuticals provides contract development and manufacturing services to other pharmaceutical enterprises. The company distributes its products through a diverse network, which includes retail pharmacy chains, wholesalers, distributors, mail-order pharmacies, and group purchasing organizations. Incorporated in 2001, its corporate headquarters are situated in Baudette, Minnesota.
| Employees | 897 |
| Beta | 0.44 |
| Sales or Revenue | $486.82M |
| 5Y Sales Change% | 0.567% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |